Apolipoprotein E gene polymorphism and left ventricular function in Iranian patients with thalassemia major

Haematologica

Volumn 92, Issue 2, 2007, Pages 256-257

  Bazrgar, Masood ^a   Karimi, Mehran ^b   Peiravian, Farah ^c   Fathzadeh, Mohsen ^a  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Shiraz University of Medical Sciences   (Iran)

Author keywords

Apolipoprotein E; Left ventricular function; Thalassemia

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEART LEFT VENTRICLE FUNCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; THALASSEMIA MAJOR; BETA THALASSEMIA; CHILD; GENETICS; LETTER; RISK FACTOR;

ADOLESCENT; ADULT; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BETA-THALASSEMIA; CHILD; FEMALE; HUMANS; IRAN; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33947525583     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10708     Document Type: Article

References (11)

1. Lomnitski L, Chapman S, Hochman A, kohen R, Shohmi E, Chen Y, et al. Antioxidant mechanisms in apolipoprotein E-deficient mice prior to and following closed head injury. Biochem Biophys Acta 1999;1453:359-68.
2. Economou-Petersen E,Aessopos A, Kladi A, Flevari P, Karabatsos F, Fragodimitric, et al. Apolipoprotein E 4 allele as a genetic risk factor for left ventricular failure in homozygous β-thalassemia. Blood 1998;92:3455-9.
3. Ferrara M, Matarese SM, Francese M, Borelli B, Copolla L, Copolla A, et al. Role of apolipoprotein E (apoE) polymorphism on left cardiac failure in homozygous β-thalassemia patients. Br J Haematol 2001;114:959-60.
4. Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann C-F, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000;83:667-72.
5. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1159-60.
6. Reardon CA. Differential metabolism of apolipoprotein E isoproteins. J Lab Clin Med 2002;140:301-2.
7. Hanis CL, Hewett-Emmet D, Dauglas TC, Bertin TK, Schull WT. Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins and apolipoproteins among Mexican-Americans in star county, Texas. Ateroscler Thromb 1991;11:362-70.
8. Ti Z-S, Pitas RE, Mahley RW. Differential cellular accumulation retention of apolipoprotein E mediated by cell surface heparin sulfate proteoglycans. Apolipoprotein E3 and E2 greater than E4 J Biol Chem 1998;273:13452-60.
9. Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesberg WR, et al. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J Neuropathol Exp Neurol 1997;57:415-25.
10. Sabbah HN. Apoptotic cell death in heart failure. Cardiovasc Res 2000;45:704-12.
11. Peroutka SJ, Dreon DM. The Value of genotyping for apolipoprotein E alleles in relation to vitamin E supplementation. Eur J Pharmacol 2000;410:161-3.